Close
Patheon

News Releases

  • 08 Jun 2017

    Highlights:

    • 2Q 2017 revenue of $483 million
    • Net income from continuing operations of $28 million
      • Net income from continuing operations per diluted share of $0.19
    • 2Q 2017 Adjusted EBITDA of $94 million
    • Adjusted net income from continuing operations of $29 million
      • Adjusted net income from continuing operations per diluted share of $0.20
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. (NYSE: PTHN), a leading global provider of pharmaceutical development and manufacturing services, today reported financial results for the quarter ended April 30, 2017. Second quarter 2017 revenue was $483 million, compared to $469 million in the prior-year period, and second quarter 2017 adjusted EBITDA was $94 million, compared to $98 million in the prior-year period. Revenue for the first six months of fiscal 2017 was $more...
  • 16 Mar 2017

    Highlights:

    • 1Q 2017 revenue increased by 13% year-over-year to $457M
    • Net income from continuing operations was $28M
      • Net income from continuing operations per diluted share was $0.19
    • 1Q 2017 Adjusted EBITDA was $83M, or 18% of revenue, a 350 bp year-over-year improvement
    • Adjusted net income from continuing operations was $21M
      • Adjusted net income from continuing operations per diluted share was $0.14
    • Updated financial outlook for fiscal year 2017
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. (NYSE: PTHN), a leading global provider of pharmaceutical development and manufacturing services, today reported financial results for the quarter ended January 31, 2017. First quarter 2017 revenue was $457 million, an increase of 13% compared to the first quarter of 2016. Adjusted EBITDA in the first quarter was $83 million, 40% higher than the prior-year period. Adjusted EBITDA margin as a percentage of revenue was 18%,more...
  • 03 Mar 2017
    DURHAM, N.C.--(BUSINESS WIRE)--Patheon N.V. (NYSE: PTHN), a leading global provider of pharmaceutical development and manufacturing services, today announced that it will release financial results for the first fiscal quarter 2017 on Thursday, March 16, 2017 before the market opens. Patheon’s management – Jim Mullen, CEO; Michel Lagarde, President; and Stuart Grant, CFO, will host a conference call and webcast to discuss the results on Thursday, March 16, 2017 at 8:more...

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com

 
 

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com